Biomerica (BMRA) Interest Coverage Ratio (2010 - 2026)
Biomerica (BMRA) reported Interest Coverage Ratio of 649.0 for Q1 2026, down 1294.55% on a YoY basis from 54.33 in Q1 2025, and down 13607.94% sequentially from 4.73 in Q4 2025.
Biomerica (BMRA) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Biomerica (BMRA) has 17 years of Interest Coverage Ratio data on file, last reported at 649.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio fell 1294.55% year-over-year to 649.0; the trailing twelve-month figure through Feb 2026 stood at 2676.5 (down 1264.76% YoY), and the FY2025 full-year result was 0.44, up 28.79% from the prior year.
- Interest Coverage Ratio eased to 649.0 in Q1 2026, from 4.73 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.02 in Q1 2022 to a low of 649.0 in Q1 2026.
- A 5-year average of 51.64 and a median of 14.16 in 2023 frame the typical range for Interest Coverage Ratio.
- Peak annual rise in Interest Coverage Ratio reached 99.96% in 2022, while the deepest fall reached 9628.73% in 2022.
- Tracing BMRA's Interest Coverage Ratio over 5 years: stood at 10.82 in 2022, then tumbled by 74.87% to 18.92 in 2023, then slumped by 49.97% to 28.37 in 2024, then soared by 83.31% to 4.73 in 2025, then tumbled by 13607.94% to 649.0 in 2026.
- Business Quant data shows BMRA's Interest Coverage Ratio at 649.0 in Q1 2026, 4.73 in Q4 2025, and 12.15 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.90 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 13.19 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.15 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.19 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 82.35 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -2.90 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.36 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | -649.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -649.00 |
| Nov 30, 2025 | -4.73 |
| Aug 31, 2025 | -12.15 |
| May 31, 2025 | -17.00 |
| Feb 28, 2025 | -46.54 |
| Nov 30, 2024 | -28.37 |
| Aug 31, 2024 | -15.20 |
| May 31, 2024 | -17.17 |
| Feb 29, 2024 | -2.14 |
| Nov 30, 2023 | -18.92 |
| Aug 31, 2023 | -14.16 |
| May 31, 2023 | -10.61 |
| Feb 28, 2023 | -1.26 |
| Nov 30, 2022 | -10.82 |
| Aug 31, 2022 | -24.07 |
| May 31, 2022 | -5.72 |
| Feb 28, 2022 | -0.02 |
| Nov 30, 2021 | -0.17 |
| Aug 31, 2021 | -0.25 |
| May 31, 2021 | -15,516.22 |